Related Experiment Video
Updated: Aug 6, 2026
14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Gentamicin-susceptible or gentamicin-resistant methicillin-resistant Staphylococcus aureus: a case-case study
Jérôme Robert1, Roland Bismuth, Nadine Lemaitre
1Laboratoire de Bactériologie-Hygiène, Faculté de Médecine Pitié-Salpétriêre, Université Pierre et Marie Curie, Paris, France. jrobert@chups.jussieu.fr
Infection Control and Hospital Epidemiology
|July 29, 2006
Summary
Gentamicin-susceptible MRSA strains are increasing. Patient exposure is key for GS-MRSA, while beta-lactam antibiotics drive GR-MRSA acquisition, not GS-MRSA.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant healthcare-associated pathogen.
- Shifting dynamics in MRSA epidemiology show a rise in gentamicin-susceptible strains (GS-MRSA) replacing gentamicin-resistant strains (GR-MRSA).
Purpose of the Study:
- To investigate the epidemiological factors associated with the increasing prevalence of GS-MRSA.
- To identify risk factors for the acquisition of both GS-MRSA and GR-MRSA.
Main Methods:
- Retrospective analysis of patient data.
- Risk factor assessment for MRSA acquisition.
Main Results:
- Exposure to other patients colonized with GS-MRSA was the primary risk factor for GS-MRSA acquisition.
- Antimicrobial exposure, particularly beta-lactams, was significantly associated with GR-MRSA acquisition but not GS-MRSA acquisition.
- Gentamicin use showed an association with GR-MRSA acquisition only in univariate analysis.
Conclusions:
- Patient-to-patient transmission is the main driver for GS-MRSA spread.
- The acquisition patterns of GS-MRSA and GR-MRSA differ, with distinct antimicrobial associations.
- Understanding these transmission dynamics is crucial for infection control strategies targeting MRSA.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...